Ligand validation:6BR6

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6BR6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BR6_NAG_A_501	34%	63%	0.128	0.807	0.73	0.68	-	1	0	0	100%	1
4GZT_NAG_B_508	46%	37%	0.154	0.888	0.6	1.82	-	4	0	0	100%	1
4GZW_NAG_C_811	37%	61%	0.202	0.898	0.48	0.99	-	1	0	0	100%	1
4GZQ_NAG_A_509	23%	47%	0.229	0.854	0.46	1.56	-	1	0	0	100%	1
4GZX_NAG_A_809	21%	48%	0.183	0.792	0.54	1.45	-	3	1	0	100%	1
4GZO_NAG_A_508	18%	53%	0.254	0.845	0.63	1.19	-	1	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.